In recent trading sessions, the Hang Seng Index has experienced notable fluctuations, reflecting broader global economic uncertainties and specific regional challenges. Amid these conditions, investors might find particular value in growth companies with high insider ownership, as these firms often demonstrate alignment between management’s interests and those of shareholders, potentially offering resilience in turbulent times.
Top 10 Growth Companies With High Insider Ownership In Hong Kong
Overview: Xiamen Yan Palace Bird's Nest Industry Co., Ltd. operates in the People’s Republic of China, focusing on the research, development, production, and marketing of edible bird’s nest products, with a market capitalization of approximately HK$6.53 billion.
Operations: The company generates revenue through several segments, including CN￥16.75 million from online distributors, CN￥509.04 million from offline distributors, CN￥824.40 million from direct sales to online customers, CN￥351.17 million from direct sales to offline customers, and CN￥262.89 million from sales to e-commerce platforms.
Insider Ownership: 26.7%
Earnings Growth Forecast: 14.8% p.a.
Xiamen Yan Palace Bird's Nest Industry Co., Ltd. is experiencing steady revenue growth, with expectations to reach RMB 1.09 billion in the first half of 2024, up by approximately 15% year-over-year. However, projected net profit for the same period shows a significant drop of nearly 50%, indicating potential challenges ahead despite robust sales performance. The company maintains a strong insider ownership structure and is poised to outpace Hong Kong's market earnings growth forecast at an annual rate of 14.8%.
Overview: Alibaba Health Information Technology Limited operates primarily in pharmaceutical direct sales, pharmaceutical e-commerce platforms, and healthcare and digital services across Mainland China and Hong Kong, with a market capitalization of approximately HK$52.10 billion.
Operations: The company generates revenue through its pharmaceutical and healthcare business, which amounted to CN￥27.03 billion.
Insider Ownership: 24.2%
Earnings Growth Forecast: 23.7% p.a.
Alibaba Health Information Technology has demonstrated robust earnings growth, with a 65.6% increase over the past year and further significant growth expected at an annual rate of 23.7%. Despite trading at 62.9% below its estimated fair value, challenges include shareholder dilution and low forecasted Return on Equity of 13.6% in three years. Recent activities include a positive earnings report for FY2024 with net income rising to CNY 883.48 million from CNY 535.65 million the previous year, underscoring its potential amidst concerns.
Overview: Meituan is a technology retail company based in the People's Republic of China, with a market capitalization of approximately HK$720.84 billion.
Operations: The company generates its revenue from technology retail operations in China.
Insider Ownership: 11.5%
Earnings Growth Forecast: 31.3% p.a.
Meituan has shown a very large earnings increase of 568.2% over the past year, with revenue growth expected at 12.8% per year, outpacing the Hong Kong market's 7.8%. However, there's been significant insider selling recently and no substantial insider purchases in the last three months. Despite this, earnings are projected to grow by 31.3% annually over the next three years, significantly above the market forecast of 11.5%. Recently, Meituan announced a CNY 73 billion sales for Q1 2024 and initiated a US$2 billion share buyback program.
Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include SEHK:1497 SEHK:241 and SEHK:3690.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]